Currently in:
Lung Cancer
More Searches ...

Lung Cancer Causes
Lung Cancer Stages
Lung Cancer Symptoms
Lung Cancer Treatment
Lung Cancer
Lung Tumor
Lung Disease

Statement by HHS Secretary Kathleen Sebelius and HHS Agencies on the Signing of the Family Smoking Prevention and Tobacco Control Act

President Obama took historic action to save lives, reduce health care costs, and help reduce suffering from heart and lung diseases, cancer, and other tobacco-related illnesses. These illnesses kill hundreds of thousands of Americans every year, and the new law gives us the tools to effectively address (continued...)

Field Fisher Waterhouse Wins Compensation For Lung Cancer Sufferer Exposed To Asbestos

Field Fisher Waterhouse has announced a significant compensation win for a client suffering from lung cancer who was exposed to asbestos (continued...)

Lung Cancer Due to Asbestos a World Wide Concern

Even though investigations have found the incidence of occurrence of asbestosis, a lung condition, in the Libby, Montana area to be higher than the U.S. national average for the period from 1979-1998, it has nothing on the Nahariya, Israel or Genoa, Italy. Genoa, is the leader of world lung cancer (continued...)

Antigenics' QS-21 Adjuvant Enters Pivotal Phase 3 Clinical Trial Of GlaxoSmithKline's Malaria Vaccine

Antigenics Inc. (NASDAQ: AGEN) announced that GlaxoSmithKline (GSK) has launched a Phase 3 study with the world's most clinically-advanced malaria vaccine, RTS,S, which contains Antigenics' QS-21 Stimulon® adjuvant. "There are now approximately 15 vaccines containing QS-21 in clinical trials of which (continued...)

UCLA Cancer Researchers Develop Model That May Help Identify Lung Cancer Stem Cells

Researchers at UCLA's Jonsson Comprehensive Cancer Center, on a quest to find lung cancer stem cells, have developed a unique model to allow further investigation into the cells that many believe may be at the root of all lung cancers. (continued...)

Marijuana Damages DNA And May Cause Cancer

Using a highly sensitive new test, scientists in Europe are reporting "convincing evidence" that marijuana smoke damages the genetic material DNA in ways that could increase the risk of cancer. Their study can be found in the June 15 issue of ACS' Chemical Research in Toxicology, a monthly journal. (continued...)

OSI Pharmaceuticals Announces Acceptance Of Tarceva Supplemental New Drug Application For Review By The U.S. Food And Drug Administration

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the supplemental New Drug Application (sNDA) for the use of Tarceva® (erlotinib) as a first-line maintenance treatment for patients with advanced non-small cell lung (continued...)

UCLA cancer researchers develop model that may help identify cancer stem cells

(University of California - Los Angeles) Researchers at UCLA's Jonsson Comprehensive Cancer Center, on a quest to find lung cancer stem cells, have developed a unique model to allow further investigation into the cells that many believe may be at the root of all lung cancers. (continued...)

Lung Cancer Alliance Issues Statement on FDA Tobacco Regulation Bill

Urges Comprehensive Approach to Addressing Lung Cancer WASHINGTON, June 12 /PRNewswire-USNewswire/ -- Today, the U.S. House of Representatives overwhelmingly endorsed the U.S. (continued...)

Lung Cancer Risks Rise With Nanoparticles

Research on the cause of lung cancer has been one of exhaustive studies. Much research in recent years has attempted to answer the question of why some individuals whom share similar traits, such as smokers, develop lung cancer, while others from the same cohort do not. Some studies have indicated (continued...)

lung-tumors.info - Lung cancer tumors

Latest news and articles about Lung cancer. Up-to-date information about the Symptoms of Lung Cancer, lung tumors, causes and possible treatments. In order to read the article, please click on more... below the article. For more topics click on the left hand menu

Lung Cancer

Higher Leverage Against Lung Cancer

The fight against cancer has been progressively advancing through the years. Combined efforts from the government, civil society, and health advocacy groups have gained dramatic results. Cancer awareness is on the rise, alternative less cancer-prone lifestyles are arising, while medical researches and technological advancement have tremendously leveled up the fight against one of the world's leading killer. The classic chemotherapy has been modernized and combined with other treatments like radiation, laser, and even organic medicines.

In America alone, the National Health Institute of the US Department of Health and Human Services through its anti-cancer arm National Cancer Institute reported that the death rate due to cancer is still on the decline. In it's annual report to the nation, the NCI claimed that the cancer death rates are progressively declining and progress in cancer treatments are continuously on the rise. In men, study from 1993 to 2002 recorded a decline of 1.5 percent death rate from all cases of cancer. This is higher compared to women's 0.08 percent decline rate.

This report has put the US Department of Health and Human Services at a better position in achieving the goals of its Health People 2010 campaign. The statistics revealed that lung cancer is still consistently leading the nation's cancer death rates. Although a decrease in tobacco-related cancer cases is being achieved, the challenge to drastically reduce its death toll is still as hard as it has always been before. With more and more people puffing cigarettes, lung or bronco cancer is still the leading cause of cancer deaths among men and women.

Dubbed as "the most common cancer", lung cancer is now the subject of numerous studies and experimentations in many countries with advance cancer research programs and facilities like the United Kingdom and Australia. A wider knowledge on lung cancer is now available. A classification has been made between Small Cell Lung Cancer and Non-Small Cell Lung Cancer. Small cell lung cancer is the case where in malignant cancer cells grow in the tissues of the lungs. Three types of Small Cell Lung Cancer are known: small cell carcinoma, large cell carcinoma, and combined small cell carcinoma. Smoking, second hand smoking, and exposure to asbestos and radon are the known causes of Small Cell Lung Cancer. Current treatments do not successfully cure cases of Small Cell Lung Cancer. However, studies in Germany revealed that surgery (removal of cancer cells or tumor), systematic post-surgery chemotherapy, and sustained local treatments (e.g. *radiation therapy*) have a higher probability of curing this type of lung cancer.

Non-Small Cell Lung Cancer, on the other hand, is the most common type of lung cancer. It accounts for four of every five deaths from lung cancer. There are several known types of Non-Small Lung Cancer, the three most common are the Squamous Cell Carcinoma, Large Cell Carcinoma, and Adenocarcinoma. The others are pleomorphic, carcinoid tumor, and salivary gland carcinoma. Like the other lung cancer type, Non-Small Cell Lung Cancer is mostly caused by smoking (first and second hand), high exposure to air pollution, and exposure to chemicals like asbestos, chromium, and arsenic.

In 2005, the New England Journal of Medicine reported a breakthrough in treatment for Non-Small Cell Lung Cancer. It reported that current studies reveal that chemotherapy, after the traditional Non-Small Cell Lung Cancer treatment of surgery, can increase the survival rate among patients. In a study, an overwhelming 15 percent increase of survival rate was recorded among patients who had chemotherapy after surgery. Sixty-nine percent of those who had post-surgery chemotherapy's were reported to be still alive five years after the surgery compared to the 54 percent who did not.

Furthermore, a study in Switzerland suggested an even greater breakthrough for Non-Small Cell Lung Cancer treatment. The study proposed that in addition to chemotherapy, a combination of the innovative cancer drugs Tarceva and Avastin can lead to higher survival rate for Non-Small Cell Lung Cancer patients. Tarceva is approved in the US and across the European Union for patients with unsuccessful cancer treatments through chemotherapy. Also in US and Europe, Avastin is a popular effective medicine for colorectal cancer, non-small cell lung cancer, and breast cancer. The proposed combination is seen to serve as a stronger combat against Non-Small Cell Lung Cancer, especially for the recurring cases.

In the US, the Health and Human Services Department clearly targets the habit of smoking as the main antagonist in the fight against lung cancer. A propaganda campaign is almost everywhere to make Americans, if not totally quit, slowdown on smoking.

For more valuable information on Cancer, Heart Health, and Infectious Diseases, please visit www.healthsnippets.com

News Rss
Articles Rss